c-kit gene mutation at exon 17 or 13 is very rare in sporadic gastrointestinal stromal tumors

Journal of Gastroenterology and Hepatology (Australia)

Volumn 18, Issue 2, 2003, Pages 147-151

  Kinoshita, Kazuo ^a   Isozaki, Koji ^a   Hirota, Seiichi ^a   Nishida, Toshirou ^a   Chen, Hui ^a   Nakahara, Masanori ^a   Nagasawa, Yutaka ^a   Ohashi, Akiko ^a   Shinomura, Yasuhisa ^a   Kitamura, Yukihiko ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

c kit; Exon 13; Exon 17; Gastrointestinal stromal tumor; Mutation

Indexed keywords

FORMALDEHYDE; GENOMIC DNA; PARAFFIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; DNA DETERMINATION; DNA EXTRACTION; EXON; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MALE; MITOSIS; MUTATIONAL ANALYSIS; ONCOGENE C KIT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TISSUE FIXATION;

EID: 0037298918     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2003.02911.x     Document Type: Article

References (28)

1. Chabot B, Stephenson DA, Chapman VM, Besmer P, Bernstein A. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 1988; 335: 88-9.
2. Geissler EN, Ryan MA, Housman DE. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 1988; 55: 185-92.
3. Besmer P, Murphy JE, George PC et al. A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature 1986; 320: 415-21.
4. Yarden Y, Kuang WJ, Yang-Feng T et al. Human proto-oncogene c-kit: a new cell surface receptor tyrosinekinase for an unidentified ligand. EMBO J. 1986; 6: 3341-51.
5. Qiu FH, Ray P, Brown K et al. Primary structure of c-kit: relationship with the CSF-1/PDGF receptor tyrosine kinase family - oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J. 1998; 7: 1003-11.
6. Williams DE, Eisenman J, Baird A et al. Identification of a ligand for the c-kit proto-oncogene. Cell 1990; 63: 167-74.
7. Russell ES. Hereditary anemias of the mouse: a review for geneticists. Adv. Genet. 1979; 20: 357-459.
8. Kitamura Y, Go S. Decreased production of mast cells in S1/S1d anemic mice. Blood 1979; 53: 492-7.
9. Huizinga JD, Thuneberg L, Klpel M, Malysz J, Mikkelsen HB, Bernstein A. W/kit gene required for intestinal cells of cajal and for intestinal pacemaker activity. Nature 1995; 373: 347-9.
10. Isozaki K, Hirota S, Nakama A et al. Disturbed intestinal movement, bile reflux to the stomach, and deficiency of c-kit-expressing cells in Ws/Ws mutant rats. Gastroenterology 1995; 109: 456-64.
11. Fishman AP. Gastrointestinal tract. In: Rosai J, ed. Ackerman's Surgical Pathology, 8th edn. St. Louis: Mosby, 1996; 645-7.
12. Hirota S, Isozaki K, Moriyama Y et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279: 577-80.
13. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am. J. Pathol. 1998; 152: 1259-69.
14. Sircar K, Hewlett BR, Huizinga JD, Choneyko K, Berezin I, Riddell R. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am. J. Surg. Pathol. 1999; 23: 377-89.
15. Taniguchi M, Nishida T, Hirota S et al. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res. 1999; 59: 4297-300.
16. Lasota J, Jasinski M, Sarlomo-Rikala M, Miettinen M. Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am. J. Pathol. 1999; 154: 53-60.
17. Sakurai S, Fukasawa T, Chong JM, Tanaka A, Fukayama M. C-kit gene abnormalities in gastrointestinal stromal tumors (tumors of interstitial cells of Cajal). Jpn J. Cancer Res. 1999; 90: 1321-8.
18. Lux ML, Rubin BP, Blase TL et al. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. Am. J. Pathol. 2000; 156: 791-5.
19. Lasota J, Wozniak A, Sarlomo-Rikala M, Rys J, Sobin LH, Miettinen M. Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases. Am. J. Pathol. 2000; 157: 1091-5.
20. Hirota S, Nishida T, Isozaki K et al. Gain-of-function mutation at extracellular domain of KIT in gastrointestinal stromal tumors. J. Pathol. 2001; 193: 505-10.
21. Sakurai S, Oguni S, Hironaka M, Fukayama M, Morinaga S, Saito K. Mutations in c-kit gene exons 9 and 13 in gastrointestinal stromal tumors among Japanese. Jpn J. Cancer Res. 2001; 92: 494-8.
22. Nagata H, Worobec AS, Oh CK et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc. Natl Acad. Sci. USA 1995; 92: 10 560-4.
23. Nakata Y, Kimura A, Katoh O et al. C-kit point mutation of extracellular domain in patients with myeloproliferative disorders. Br. J. Haematol. 1995; 91: 661-3.
24. Tian Q, Frierson HF, Krystal GW, Moskaluk CA. Activating c-kit mutations in human germ cell tumors. Am.J. Pathol. 1999; 154: 1643-7.
25. Gari M, Goodeve A, Wilson G et al. C-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukemia. Br. J. Haematol. 1999; 105: 894-900.
26. Hirota S, Nishida T, Isozaki K et al. Familial gastrointestinal stromal tumors associated with dysphagia and novel type germline mutation of KIT gene. Gastroenterology 2002; 122: 1493-9.
27. Hongyo T, Buzard GS, Calvert RJ, Weghorst CM. 'Cold SSCP': a simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses. Nucl. Acids Res. 1993; 21: 3637-42.
28. Isozaki K, Terris B, Belghiti J, Schiffmann S, Hirota S, Vanderwinden JM. Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors. Am. J. Pathol. 2000; 157: 1581-5.